Chiara Martinoli, Andrea Chiavelli, Maria Rescigno  Immunity 

Slides:



Advertisements
Similar presentations
Volume 40, Issue 4, Pages (April 2014)
Advertisements

Volume 45, Issue 6, Pages (December 2016)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles  Kathryn A. Pape, Drew M. Catron,
Volume 25, Issue 2, Pages (August 2006)
Volume 43, Issue 3, Pages (September 2015)
Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection
Volume 26, Issue 3, Pages (March 2007)
Volume 11, Issue 3, Pages (March 2012)
Volume 21, Issue 6, Pages (December 2004)
Wei Hu, Ty Dale Troutman, Ramakrishna Edukulla, Chandrashekhar Pasare 
Volume 34, Issue 3, Pages (March 2011)
Volume 31, Issue 2, Pages (August 2009)
Volume 38, Issue 4, Pages (April 2013)
Volume 8, Issue 6, Pages (June 1998)
Volume 36, Issue 4, Pages (April 2012)
Volume 36, Issue 5, Pages (May 2012)
Volume 18, Issue 5, Pages (May 2003)
Volume 28, Issue 2, Pages (February 2008)
Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis
Volume 29, Issue 2, Pages (August 2008)
Volume 4, Issue 4, Pages (October 2008)
Volume 17, Issue 5, Pages (May 2015)
Volume 31, Issue 2, Pages (August 2009)
Volume 42, Issue 4, Pages (April 2015)
Volume 7, Issue 2, Pages (February 2010)
Volume 36, Issue 5, Pages (May 2012)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Volume 36, Issue 2, Pages (February 2012)
Volume 29, Issue 6, Pages (December 2008)
Volume 40, Issue 4, Pages (April 2014)
Volume 45, Issue 6, Pages (December 2016)
Adam C. Silver, Alvaro Arjona, Wendy E. Walker, Erol Fikrig  Immunity 
Volume 44, Issue 3, Pages (March 2016)
Volume 44, Issue 3, Pages (March 2016)
Volume 34, Issue 4, Pages (April 2011)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Volume 41, Issue 5, Pages (November 2014)
Volume 134, Issue 4, Pages (April 2008)
Novel Role of the Ras Cascade in Memory B Cell Response
Volume 25, Issue 6, Pages (December 2006)
Volume 29, Issue 6, Pages (December 2008)
Volume 43, Issue 3, Pages (September 2015)
Volume 31, Issue 5, Pages (November 2009)
Interferon-γ-Responsive Nonhematopoietic Cells Regulate the Immune Response to Mycobacterium tuberculosis  Ludovic Desvignes, Joel D. Ernst  Immunity 
Volume 44, Issue 4, Pages (April 2016)
Volume 36, Issue 6, Pages (June 2012)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Oral Tolerance Can Be Established via Gap Junction Transfer of Fed Antigens from CX3CR1+ Macrophages to CD103+ Dendritic Cells  Elisa Mazzini, Lucia Massimiliano,
Volume 30, Issue 2, Pages (February 2009)
Volume 14, Issue 2, Pages (August 2013)
Volume 127, Issue 5, Pages (November 2004)
Volume 38, Issue 3, Pages (March 2013)
Volume 24, Issue 3, Pages (March 2006)
CD40, but Not CD40L, Is Required for the Optimal Priming of T Cells and Control of Aerosol M. tuberculosis Infection  Vanja Lazarevic, Amy J Myers, Charles.
CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
Volume 21, Issue 6, Pages (December 2004)
Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 
Volume 46, Issue 4, Pages (April 2017)
Volume 37, Issue 6, Pages (December 2012)
Volume 34, Issue 5, Pages (May 2011)
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 12, Issue 2, Pages (July 2015)
Volume 28, Issue 5, Pages (May 2008)
Volume 36, Issue 5, Pages (May 2012)
Volume 7, Issue 5, Pages (May 2010)
Volume 33, Issue 5, Pages (November 2010)
The Coinhibitory Receptor CTLA-4 Controls B Cell Responses by Modulating T Follicular Helper, T Follicular Regulatory, and T Regulatory Cells  Peter T.
Volume 30, Issue 2, Pages (February 2009)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Entry Route of Salmonella typhimurium Directs the Type of Induced Immune Response  Chiara Martinoli, Andrea Chiavelli, Maria Rescigno  Immunity  Volume 27, Issue 6, Pages 975-984 (December 2007) DOI: 10.1016/j.immuni.2007.10.011 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 S. typhimurium Colonization of Peyer's Patches after Oral Infection Depends on Active Type-Three Secretion System (A) C57BL/6 mice (n = 12/group) were left untreated (NT) or fed with 107 CFUs of invasive (InvA+) or 108 CFUs of noninvasive (InvA−) replicating S. typhimurium. Six days after infection, mice were sacrificed. Culturable bacteria in Peyer's patches (PP, left), mesenteric lymph nodes (MLN, middle), and spleens (SP, right) are shown. No bacteria were found in untreated mice. Data are presented as mean ± standard error (SE) and are pooled from five experiments. ∗ indicates p < 0.05. (B) C57BL/6 mice were left untreated (left column) or fed with 0.5 × 109 CFUs of invasive (middle column) or 109 CFUs of noninvasive (right column) S. typhimurium. After 18 hr, PPs were collected and embedded in OCT compound. Cryosections were stained with Salmonella sp. antiserum (rabbit), HRP-conjugated anti-rabbit and developed with DAB reagent. Sections were counterstained with hematoxilin. The top row shows intestininal ileal villi staining at 20× magnification, the bottom row shows Peyer's patches staining at 40× magnification, and the inset shows a 5× magnification of one representative section. (C) Invasive and noninvasive S. typhimurium have the same capability to survive in the mouse gastrointestinal tract. C57BL/6 mice (n = 4/group) were fed with 109 CFUs of recombinant pDsRed S. typhimurium (aroA, invasive; aroAinvA, noninvasive). Total feces were collected from single mice every 2 hr, and serial dilutions were plated onto TB-agar plates supplemented with IPTG for the evaluation of S. typhimurium viability. Data are presented as mean ± SE (millions of recovered bacteria) and are pooled from two experiments. Immunity 2007 27, 975-984DOI: (10.1016/j.immuni.2007.10.011) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 Invasive S. typhimurium Induces Mucosal IgA Response (A and B) C57BL/6 mice (n = 6/group) were fed with 109 CFUs of invasive (aroA, black bars) or noninvasive attenuated S. typhimurium (aroAinvA, gray bars) three times on alternate days. Serum and fecal samples were collected before the infection and weekly for 6 weeks after the infection. The presence of S. typhimurium specific IgG in serum (A) and IgA in feces (B) was evaluated by ELISA. Data are presented as mean ± SE of OD450 and are representative of six independent experiments. In (B) ∗ indicates that starting from week 2, the content of Salmonella-specific IgA in samples from mice that received the two vaccination regimens is statistically significantly different. (C) C57BL/6 mice were left untreated (left column) or fed with 109 CFUs of aroA (middle column) or aroAinvA (right column) S. typhimurium three times on alternate days. Seven days after the last infection, mice were sacrificed, and PPs were collected and embedded in OCT compound. Cryosections were stained with anti-mouse IgA (rabbit), HRP-conjugated anti-rabbit and developed with DAB reagent. Sections were counterstained with hematoxilin. The top row shows 10× magnification; the bottom row shows 20× magnification of one representative section (insets represent digital zooms of selected IgA-enriched areas). (D) C57BL/6 mice (n = 3/group) were left untreated (NT) or fed with 109 CFUs of aroA or aroAinvA S. typhimurium. PPs were collected 2, 4, and 6 weeks after the infection. The presence of Salmonella-specific IgA antibody-secreting cells (ASC) was evaluated by ELIspot. Immunity 2007 27, 975-984DOI: (10.1016/j.immuni.2007.10.011) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 3 Noninvasive S. typhimurium Promotes IgA Production In Vitro (A) The percentage of IgM- and IgA-positive cells in freshly isolated PP samples was evaluated by flowcytometry (left, day 0). The percentage of total IgA-positive cells 7 days after infection with invasive or noninvasive HEL-expressing bacteria was evaluated by flow cytometry (right, day 7). (B and C) Total cells (106) from the PP, MLN, or SP of BCR-HEL VDJ ki mice were left untreated (NT, white bars) or cocultured for 4 hr with aroA (black and dark gray bars) or aroAinvA (medium and light gray bars) S. typhimurium that expressed or did not express HEL. Seven days after the infection, the presence of HEL-specific IgG (B) or IgA (C) in supernatants was evaluated by ELISA. Data are presented as mean of OD450 ± SE and are representative of three experiments. Immunity 2007 27, 975-984DOI: (10.1016/j.immuni.2007.10.011) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 4 Invasive S. typhimurium Activates the Immune System in Peyer's Patches (A–D) C57BL/6 mice (n = 4–5/group) were left untreated (NT, white) or fed with 107 CFUs of InvA+ (black) or 108 CFUs of InvA− (gray) replicating S. typhimurium. Six days after infection, mice were sacrificed, and PPs, MLNs, and SPs were collected. IL-1β in total cell lysates was measured by ELISA (A). Each dot represents an individual mouse. Lines show mean values. Increment in MHC class I and CD86 expression on CD11c+ gated cells in the PP (B), MLN (C), and SP (D) was evaluated in treated versus untreated mice. (E–G) C57BL/6 mice (n = 4/group) were left untreated (NT, white) or fed with 109 CFUs of aroA (black) or aroAinvA (gray) attenuated S. typhimurium three times on alternate days. Four days after the last infection, mice were sacrificed, and PPs, MLNs, and SPs were collected. Increment in MHC class II, CD86 and CD40 expression on CD19+ gated cells in the PP (E), MLN (F), and SP (G) was evaluated in treated versus untreated mice. (B–G) Data are presented as mean ± SE of the ratio MFI (treated)/MFI (untreated). ∗ indicates p < 0.05 when compared to other samples of the same group. Immunity 2007 27, 975-984DOI: (10.1016/j.immuni.2007.10.011) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 5 Intestinal IgAs Protect Mice against Oral Challenge with Pathogen S. typhimurium Kaplan-Meier survival curves of C57BL/6 mice (n = 9–13/group) left untreated (light gray line) or fed with 109 CFUs of aroA (black line) or aroAinvA (gray line) S. typhimurium three times on alternate days. Six weeks after vaccination, mice received 107 CFUs of InvA+ pathogenic S. typhimurium, and survival was monitored daily. Immunity 2007 27, 975-984DOI: (10.1016/j.immuni.2007.10.011) Copyright © 2007 Elsevier Inc. Terms and Conditions